你即將離開本站

並前往https://www.acc.org/latest-in-cardiology/clinical-trials/2021/11/12/00/29/empulse

Empagliflozin in Patients Hospitalized for Acute Heart Failure

The EMPULSE trial showed that empagliflozin was beneficial at reducing adverse events among acute decompensated heart failure patients.

確定！ 回上一頁

查詢 「EMPULSE EMPA」的人也找了：

  1. EMPULSE trial
    2.
  2. emperor-reduced
    3.
  3. EMPEROR-Preserved ppt
    4.
  4. EMPULSE trial pdf
    5.
  5. DELIVER trial
    6.
  6. EMPA-kidney
    7.
  7. EMPULSE EMPA
    8.
  8. CHIEF-HF
    9.